Insight

Renuka Iyer: A big milestone in Cholangiocarcinoma care

Renuka Iyer/roswellpark.org

Dec 18, 2024, 12:42

Renuka Iyer: A big milestone in Cholangiocarcinoma care

Renuka Iyer, Professor at Roswell Park Cancer Institute, shared a post on LinkedIn about a recent paper by Rachna Shroff, Associate Director of Clinical Investigations at the University of Arizona Cancer Center, commenting:

“Happy that S1815 is finally reported and online. A big milestone in Cholangiocarcinoma care, great teamwork from a great community. Congratulations Rachna Shroff and all the participants.”

“SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers”

Authors: Rachna Shroff et al.

More posts featuring Renuka Iyer.

Renuka Iyer is a Professor and Medical Oncologist at Roswell Park Cancer Institute. She serves as Section Chief of Gastrointestinal Medicine, Co-Leader of the Liver and Pancreas Tumor Program, Vice Chair of Faculty Recruitment and Retention, and Medical Director of Medical Oncology.

Her specialities include internal medicine, medical oncology, and oncology, with a focus on gastrointestinal and hepatopancreatic cancers.

Rachna T. Shroff, MD, MS, FASCO is an Associate Director of Clinical Investigations at the University of Arizona Cancer Center (UACC). She is the co-leader of the Gastrointestinal Clinical Research Team. She is also the Associate Dean for Clinical and Translational Research for the University of Arizona College of Medicine – Tucson.

Prof. Shroff is the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG), Chair for GI ASCO 2024 and member of the ASCO Nominating Committee. Her research focus is the development of novel therapies for pancreatic and hepatobiliary cancers.